Pharmavite, a nutrition-powered wellness company, has opened a new manufacturing and research and development facility in New Albany, Ohio. The company, which produces vitamins and supplements under brands like Nature Made, invested $250 million into the project and created 225 new jobs.
The 225,000-square-foot facility marks Pharmavite’s first in the region and includes space for future expansion. It is already producing products ready for sale and is equipped to meet rising demand for vitamin gummies, which have nearly doubled in popularity since 2019. The site also features Pharmavite’s Gummies Innovation Center of Excellence, which supports product research and development.
What people are saying
In a recent quote, Jeff Boutelle, CEO, Pharmavite, said, “Throughout our more than 50-year history, Pharmavite has established its position as the industry leader in producing high-quality vitamins and supplements here in the United States, and this new facility enables us to meet the growing demand for Nature Made vitamins and support consumers across the country on their health and wellness journeys. We chose New Albany for this significant investment after an extensive search and we’re proud to be a part of the emerging science, innovation, and technology hub in Central Ohio, and honored to be welcomed into the wellness-focused community.”
Sloan Spalding, Mayor, City of New Albany, added, “Pharmavite’s decision to invest in New Albany represents more than just a major economic development win—it reinforces the momentum we’re seeing in our growing Health and Life Sciences cluster within the New Albany International Business Park. Their mission to support health and wellness through science-backed nutrition is a natural fit for our community, where health and wellness is one of our core pillars. We are proud to welcome Pharmavite to New Albany and look forward to the positive impact they will make, both as an innovator in their industry and as a committed community partner.”
Manufacturers investing in Ohio
Amgen invests $900M to expand biologic medicines manufacturing facility in Ohio
This expansion brings Amgen’s total investment in Central Ohio to over $1.4 billion.
Kimberly-Clark invests $2B to build and expand personal care product manufacturing facilities in Ohio and South Carolina
These investments will enhance U.S. manufacturing capacity, drive product innovation, and support long-term growth for the company’s consumer brands.
First Quality Tissue invests $984M to build tissue manufacturing facility in Ohio
The new 1.6 million-square-foot facility will be located on a 1,000-acre site at the Baltimore Avenue Industrial Corridor.
Investing in American manufacturing in 2025
This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.